Copyright Reports & Markets. All rights reserved.

Global Mucopolysaccharidosis II Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Mucopolysaccharidosis II Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Mucopolysaccharidosis II Market Size Growth Rate by Product
      • 1.4.2 JR-141
      • 1.4.3 EGT-301
      • 1.4.4 DUOC-01
      • 1.4.5 AGT-182
      • 1.4.6 JR-032
      • 1.4.7 Others
    • 1.5 Market by End User
      • 1.5.1 Global Mucopolysaccharidosis II Market Size Growth Rate by End User
      • 1.5.2 Hospital
      • 1.5.3 Clinic
      • 1.5.4 Research Center
      • 1.5.5 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Mucopolysaccharidosis II Market Size
      • 2.1.1 Global Mucopolysaccharidosis II Revenue 2014-2025
      • 2.1.2 Global Mucopolysaccharidosis II Sales 2014-2025
    • 2.2 Mucopolysaccharidosis II Growth Rate by Regions
      • 2.2.1 Global Mucopolysaccharidosis II Sales by Regions
      • 2.2.2 Global Mucopolysaccharidosis II Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Mucopolysaccharidosis II Sales by Manufacturers
      • 3.1.1 Mucopolysaccharidosis II Sales by Manufacturers
      • 3.1.2 Mucopolysaccharidosis II Sales Market Share by Manufacturers
      • 3.1.3 Global Mucopolysaccharidosis II Market Concentration Ratio (CR5 and HHI)
    • 3.2 Mucopolysaccharidosis II Revenue by Manufacturers
      • 3.2.1 Mucopolysaccharidosis II Revenue by Manufacturers (2014-2019)
      • 3.2.2 Mucopolysaccharidosis II Revenue Share by Manufacturers (2014-2019)
    • 3.3 Mucopolysaccharidosis II Price by Manufacturers
    • 3.4 Mucopolysaccharidosis II Manufacturing Base Distribution, Product Types
      • 3.4.1 Mucopolysaccharidosis II Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Mucopolysaccharidosis II Product Type
      • 3.4.3 Date of International Manufacturers Enter into Mucopolysaccharidosis II Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Mucopolysaccharidosis II Sales by Product
    • 4.2 Global Mucopolysaccharidosis II Revenue by Product
    • 4.3 Mucopolysaccharidosis II Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Mucopolysaccharidosis II Breakdown Data by End User

    6 North America

    • 6.1 North America Mucopolysaccharidosis II by Countries
      • 6.1.1 North America Mucopolysaccharidosis II Sales by Countries
      • 6.1.2 North America Mucopolysaccharidosis II Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Mucopolysaccharidosis II by Product
    • 6.3 North America Mucopolysaccharidosis II by End User

    7 Europe

    • 7.1 Europe Mucopolysaccharidosis II by Countries
      • 7.1.1 Europe Mucopolysaccharidosis II Sales by Countries
      • 7.1.2 Europe Mucopolysaccharidosis II Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Mucopolysaccharidosis II by Product
    • 7.3 Europe Mucopolysaccharidosis II by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Mucopolysaccharidosis II by Countries
      • 8.1.1 Asia Pacific Mucopolysaccharidosis II Sales by Countries
      • 8.1.2 Asia Pacific Mucopolysaccharidosis II Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Mucopolysaccharidosis II by Product
    • 8.3 Asia Pacific Mucopolysaccharidosis II by End User

    9 Central & South America

    • 9.1 Central & South America Mucopolysaccharidosis II by Countries
      • 9.1.1 Central & South America Mucopolysaccharidosis II Sales by Countries
      • 9.1.2 Central & South America Mucopolysaccharidosis II Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Mucopolysaccharidosis II by Product
    • 9.3 Central & South America Mucopolysaccharidosis II by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Mucopolysaccharidosis II by Countries
      • 10.1.1 Middle East and Africa Mucopolysaccharidosis II Sales by Countries
      • 10.1.2 Middle East and Africa Mucopolysaccharidosis II Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Mucopolysaccharidosis II by Product
    • 10.3 Middle East and Africa Mucopolysaccharidosis II by End User

    11 Company Profiles

    • 11.1 Alexion Pharmaceuticals, Inc.
      • 11.1.1 Alexion Pharmaceuticals, Inc. Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Products Offered
      • 11.1.5 Alexion Pharmaceuticals, Inc. Recent Development
    • 11.2 AngioChem Inc.
      • 11.2.1 AngioChem Inc. Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 AngioChem Inc. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 AngioChem Inc. Mucopolysaccharidosis II Products Offered
      • 11.2.5 AngioChem Inc. Recent Development
    • 11.3 ArmaGen Inc.
      • 11.3.1 ArmaGen Inc. Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 ArmaGen Inc. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 ArmaGen Inc. Mucopolysaccharidosis II Products Offered
      • 11.3.5 ArmaGen Inc. Recent Development
    • 11.4 Bioasis Technologies Inc.
      • 11.4.1 Bioasis Technologies Inc. Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Bioasis Technologies Inc. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Bioasis Technologies Inc. Mucopolysaccharidosis II Products Offered
      • 11.4.5 Bioasis Technologies Inc. Recent Development
    • 11.5 Green Cross Corporation
      • 11.5.1 Green Cross Corporation Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Green Cross Corporation Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Green Cross Corporation Mucopolysaccharidosis II Products Offered
      • 11.5.5 Green Cross Corporation Recent Development
    • 11.6 Inventiva
      • 11.6.1 Inventiva Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Inventiva Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Inventiva Mucopolysaccharidosis II Products Offered
      • 11.6.5 Inventiva Recent Development
    • 11.7 JCR Pharmaceuticals Co., Ltd.
      • 11.7.1 JCR Pharmaceuticals Co., Ltd. Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Products Offered
      • 11.7.5 JCR Pharmaceuticals Co., Ltd. Recent Development
    • 11.8 Laboratorios Del Dr. Esteve S.A.
      • 11.8.1 Laboratorios Del Dr. Esteve S.A. Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Products Offered
      • 11.8.5 Laboratorios Del Dr. Esteve S.A. Recent Development
    • 11.9 RegenxBio Inc.
      • 11.9.1 RegenxBio Inc. Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 RegenxBio Inc. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 RegenxBio Inc. Mucopolysaccharidosis II Products Offered
      • 11.9.5 RegenxBio Inc. Recent Development
    • 11.10 Sangamo BioSciences, Inc.
      • 11.10.1 Sangamo BioSciences, Inc. Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Sangamo BioSciences, Inc. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Sangamo BioSciences, Inc. Mucopolysaccharidosis II Products Offered
      • 11.10.5 Sangamo BioSciences, Inc. Recent Development
    • 11.11 Shire Plc

    12 Future Forecast

    • 12.1 Mucopolysaccharidosis II Market Forecast by Regions
      • 12.1.1 Global Mucopolysaccharidosis II Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Mucopolysaccharidosis II Revenue Forecast by Regions 2019-2025
    • 12.2 Mucopolysaccharidosis II Market Forecast by Product
      • 12.2.1 Global Mucopolysaccharidosis II Sales Forecast by Product 2019-2025
      • 12.2.2 Global Mucopolysaccharidosis II Revenue Forecast by Product 2019-2025
    • 12.3 Mucopolysaccharidosis II Market Forecast by End User
    • 12.4 North America Mucopolysaccharidosis II Forecast
    • 12.5 Europe Mucopolysaccharidosis II Forecast
    • 12.6 Asia Pacific Mucopolysaccharidosis II Forecast
    • 12.7 Central & South America Mucopolysaccharidosis II Forecast
    • 12.8 Middle East and Africa Mucopolysaccharidosis II Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Mucopolysaccharidosis II Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Mucopolysaccharidosis II market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Mucopolysaccharidosis II market based on company, product type, end user and key regions.

      This report studies the global market size of Mucopolysaccharidosis II in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Mucopolysaccharidosis II in these regions.
      This research report categorizes the global Mucopolysaccharidosis II market by top players/brands, region, type and end user. This report also studies the global Mucopolysaccharidosis II market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Alexion Pharmaceuticals, Inc.
      AngioChem Inc.
      ArmaGen Inc.
      Bioasis Technologies Inc.
      Green Cross Corporation
      Inventiva
      JCR Pharmaceuticals Co., Ltd.
      Laboratorios Del Dr. Esteve S.A.
      RegenxBio Inc.
      Sangamo BioSciences, Inc.
      Shire Plc

      Market size by Product
      JR-141
      EGT-301
      DUOC-01
      AGT-182
      JR-032
      Others
      Market size by End User
      Hospital
      Clinic
      Research Center
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Mucopolysaccharidosis II market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Mucopolysaccharidosis II market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Mucopolysaccharidosis II companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Mucopolysaccharidosis II submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Mucopolysaccharidosis II are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Mucopolysaccharidosis II market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now